Get the Stockscreener App
4.0769
4.24%
-0.1731
Organogenesis Holdings Inc stock is traded at $4.0769, with a volume of 282.57K.
It is down -4.24% in the last 24 hours and down -5.13% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.25
Open:
$4.26
24h Volume:
282.57K
Relative Volume:
0.40
Market Cap:
$515.68M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
114.20
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-4.91%
1M Performance:
-5.13%
6M Performance:
-22.92%
1Y Performance:
+46.40%
1-Day Range:
$4.055
$4.30
1-Week Range:
$4.055
$4.39
52-Week Range:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.065 | 539.15M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
144.38 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.385 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.49 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.34 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Organogenesis Applauds CMS’s Significant Step In Payment Reform - The Manila Times
Organogenesis Holdings Inc. Commends CMS on Payment Reform for Skin Substitutes and CTPs Under CY 2026 Fee Schedule - Quiver Quantitative
Organogenesis (Nasdaq: ORGO) applauds CMS 2026: per‑cm payments, FDA classifications finalized - Stock Titan
Will Organogenesis Holdings Inc. stock maintain momentum in 2025Trade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Why Organogenesis Holdings Inc. stock could be next big winnerTrade Risk Report & Safe Entry Point Identification - newser.com
Asia Pacific Wound Care Biologics Market Growth in Future Scope - openPR.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025July 2025 Setups & High Accuracy Investment Signals - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organogenesis Holdings Inc. (ORGO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Why Organogenesis Holdings Inc. stock is trending among retail tradersBond Market & Long-Term Growth Plans - newser.com
Will Organogenesis Holdings Inc. outperform the market2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Can Organogenesis Holdings Inc. rally from current levelsWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
Why Organogenesis Holdings Inc. (2PQ) stock stays on top picksQuarterly Performance Summary & Technical Pattern Based Signals - newser.com
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Organogenesis (NASDAQ: ORGO) awards CTO inducement equity at $4.17, 4-year vesting - Stock Titan
Organogenesis Holdings Inc. (ORGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Top chart patterns to watch in Organogenesis Holdings Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Published on: 2025-10-31 05:50:02 - newser.com
What to expect from Organogenesis Holdings Inc. in the next 30 daysWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Has Organogenesis Holdings Inc. formed a bullish divergenceJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategiesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
What indicators show strength in Organogenesis Holdings Inc.2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Published on: 2025-10-31 03:32:15 - newser.com
What high frequency data says about Organogenesis Holdings Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Why pension funds invest in Organogenesis Holdings Inc. (2PQ) stockJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Organogenesis Holdings Inc. (ORGO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat
Key resistance and support levels for Organogenesis Holdings Inc.July 2025 Action & Stepwise Trade Signal Implementation - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationStop Loss & Precise Swing Trade Alerts - newser.com
Real time pattern detection on Organogenesis Holdings Inc. stockWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Organogenesis Holdings Inc. (ORGO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - WV News
Is Organogenesis Holdings Inc. stock positioned for digital transformationJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):